Kyntra Bio, Inc. (KYNB) — Working Capital to Net Assets Ratio
Kyntra Bio, Inc. (KYNB) has a Working Capital to Net Assets ratio of -746.4% as of June 2026. Working capital of $60.78 Million (current assets of $96.83 Million minus current liabilities of $36.04 Million) is measured against net assets of $-8.14 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Kyntra Bio, Inc. Working Capital to Net Assets (2012–2025)
This chart shows how Kyntra Bio, Inc.'s Working Capital to Net Assets ratio has evolved across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at -746.4%, reflecting working capital of $60.78 Million against net assets of $-8.14 Million USD. Explore Kyntra Bio, Inc. long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for Kyntra Bio, Inc. (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Kyntra Bio, Inc. from 2012 to 2025, covering 14 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Kyntra Bio, Inc. balance sheet assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1560.5% | $69.83 Million | $4.47 Million | $99.07 Million | $29.24 Million | ▲ +1594.9 pp |
| 2024 | -34.4% | $63.20 Million | $-183.63 Million | $196.51 Million | $133.31 Million | ▲ +35.8 pp |
| 2023 | -70.2% | $113.89 Million | $-162.20 Million | $331.56 Million | $217.67 Million | ▲ +14744.9 pp |
| 2022 | -14815.1% | $219.26 Million | $-1.48 Million | $492.83 Million | $273.56 Million | ▼ -14923.6 pp |
| 2021 | 108.5% | $248.56 Million | $229.11 Million | $474.06 Million | $225.50 Million | ▼ -25.6 pp |
| 2020 | 134.1% | $591.92 Million | $441.45 Million | $755.11 Million | $163.19 Million | ▲ +22.1 pp |
| 2019 | 112.0% | $599.75 Million | $535.41 Million | $702.49 Million | $102.75 Million | ▼ -1.7 pp |
| 2018 | 113.7% | $600.98 Million | $528.47 Million | $690.01 Million | $89.03 Million | ▼ -1.6 pp |
| 2017 | 115.3% | $671.71 Million | $582.45 Million | $748.97 Million | $77.26 Million | ▲ +0.3 pp |
| 2016 | 115.0% | $201.39 Million | $175.11 Million | $266.52 Million | $65.12 Million | ▲ +47.2 pp |
| 2015 | 67.8% | $133.38 Million | $196.82 Million | $200.56 Million | $67.18 Million | ▲ +11.5 pp |
| 2014 | 56.3% | $135.48 Million | $240.68 Million | $198.24 Million | $62.75 Million | ▼ -42.4 pp |
| 2013 | 98.7% | $106.16 Million | $107.60 Million | $143.64 Million | $37.48 Million | ▲ +74.8 pp |
| 2012 | 23.8% | $29.12 Million | $122.18 Million | $52.80 Million | $23.68 Million | — |